Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Mobility & Vitality Lifestyle Program (MOVE UP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02657239
Recruitment Status : Active, not recruiting
First Posted : January 15, 2016
Last Update Posted : March 28, 2019
Sponsor:
Collaborator:
Centers for Disease Control and Prevention
Information provided by (Responsible Party):
Steven M. Albert, University of Pittsburgh

Brief Summary:
MOVE UP is a weight management program for adults 60-75 in community settings led by trained community health workers.

Condition or disease Intervention/treatment Phase
Obesity Behavioral: MOVE UP Not Applicable

Detailed Description:

MOVE UP is a weight management program designed for adults who desire to lose weight and improve their overall health.

Topics include: Overall Health, Weight management, Healthy eating, Behavior change, Physical activity


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 303 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Health Promotion and Disease Prevention Research Center
Study Start Date : May 2015
Estimated Primary Completion Date : September 2019
Estimated Study Completion Date : September 2019

Arm Intervention/treatment
Experimental: MOVE UP Intervention
Subjects will participate in a healthy lifestyle weight management intervention focused on healthy eating and increasing physical activity
Behavioral: MOVE UP
Weight management behavioral program




Primary Outcome Measures :
  1. Short Physical Performance Battery [ Time Frame: 1 year ]
    Physical function objectively measured by Short Physical Performance Battery (SPPB) which includes gait speed, grip strength and chair stands, each ranked as 0-4 and summed for a total score of 0-12 units


Secondary Outcome Measures :
  1. Self-reported Physical Function [ Time Frame: 1 year ]
    Physical function self-reported with the MOS-SF36 - questions are assigned points for total points ranging fom 0-36

  2. Weight [ Time Frame: 1 year ]
    Weight in kilograms

  3. Height [ Time Frame: 1 year ]
    Height measured in meters

  4. BMI [ Time Frame: 1 year ]
    Calculated from objective measurements of height and weight above as weight in Kilograms divided height in meters-squared



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   60 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Age 60-75 at time of program start
  2. Self-reporting < 60 minutes per week of moderate structured physical activity
  3. BMI >= 30 but < 40 for screen. In person measurement on site will allow for 27-45 as inclusion criteria.
  4. Able to consent for participation and data collection
  5. Medical release before start of Weight Management
  6. Ability to walk with or without an assistive device
  7. Can regularly attend sessions
  8. Has not had bariatric surgery over the past year, or current use of weight loss prescription drug.

Exclusion Criteria:

  1. Uncontrolled diabetes mellitus (FBS > 300 & A1C > 11%) [to be assessed by physician on medical release]
  2. Uncontrolled hypertension (SBP > 180/110) %) [to be assessed by physician on medical release]
  3. Recent hospitalization (past 6 months)
  4. Active treatment for cancer (other than non-melanoma skin cancer)
  5. Significant visual or hearing impairment
  6. Dementia/psychiatric disorder
  7. Inability to communicate in English/lack of translator

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02657239


Locations
Layout table for location information
United States, Pennsylvania
Community sites
Pittsburgh, Pennsylvania, United States
Sponsors and Collaborators
University of Pittsburgh
Centers for Disease Control and Prevention
Investigators
Layout table for investigator information
Principal Investigator: Anne B. Newman, MD University of Pittsburgh

Layout table for additonal information
Responsible Party: Steven M. Albert, Principal Investigator, Chair of Department of Behavioral and Community Health Sciences, University of Pittsburgh
ClinicalTrials.gov Identifier: NCT02657239     History of Changes
Other Study ID Numbers: 1U48DP005001-01 ( U.S. NIH Grant/Contract )
First Posted: January 15, 2016    Key Record Dates
Last Update Posted: March 28, 2019
Last Verified: March 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Keywords provided by Steven M. Albert, University of Pittsburgh:
Physical Function